NIKP-Losartan Use In Pregnancy & Lactation





Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy, Delivery or Lactation: NIKP-Losartan tablet 50mg or 100mg should not be administered to pregnant women or women suspected of being pregnant. If pregnancy is discovered during administration, discontinue administration immediately. [In hypertension patients in the second or third trimester of pregnancy who were administered angiotensin II receptor antagonist, which includes ingredients of losartan potassium preparation, there are reports of oligohydramnios, fetal and newborn death, newborn hypotension, renal failure, multiple organ failure, cranial deformity, limb deformity estimated to be due to oligohydramnios, craniofacial deformity, pulmonary agenesis, etc.]
Administration of NIKP-Losartan tablet 50mg or 100mg should be discontinued during lactation. [Based on animal studies (rats), the drug has been reported to pass into the mother's milk.]
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in